Huadong Pharmaceutical Co., Ltd., a famous trademark in Zhejiang Province and a famous brand product in Zhejiang Province, is a large-scale comprehensive pharmaceutical listed company focusing on pharmaceutical industry production and pharmaceutical commercial distribution
Huadong Pharmaceutical Co., Ltd. was established in 1993, and in December 1999, the company's 50 million A shares (stock code: 000963, stock abbreviation: Huadong Medicine) were successfully issued on the Shenzhen Stock Exchange. The company is mainly engaged in the production and sales of antibiotics, Chinese patent medicines, chemical synthetic drugs, genetic engineering drugs, as well as the wholesale and retail distribution business of Chinese and Western medicines, Chinese herbal medicines, medical devices, etc., and is a large-scale comprehensive pharmaceutical listed company integrating pharmaceutical research and development, pharmaceutical industry, drug distribution and pharmaceutical logistics.
The company's business is mainly divided into two parts: pharmaceutical industry production and pharmaceutical commercial distribution, the core of the pharmaceutical industry is Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd., a holding subsidiary, which is a national high-tech enterprise, a national innovative enterprise, and one of the top 50 enterprises in China's pharmaceutical industry.
In the field of pharmaceutical commercial distribution, the company is a comprehensive large-scale pharmaceutical commercial enterprise with leading scale and strength in Zhejiang Province. The business covers hospital direct sales, commercial allocation, drug fast approval and terminal distribution. The company has a complete pharmaceutical business network and grassroots terminal market network in Zhejiang Province, and ranked 8th among the top 10 pharmaceutical commercial enterprises in China in 2011.
In 2010, the company was rated as "Top 20 Most Competitive Pharmaceutical Listed Companies in China" by China Pharmaceutical Enterprise Management Association and Pharmaceutical Manager magazine. In 2012, the company was awarded the "2011 Top 100 Golden Bull Listed Companies" by China Securities Journal, and was shortlisted again after being listed in the Fortune China 500 in 2011, ranking 324th in Fortune China, 288th in the Fortune China 500 in 2013, and the company's pharmaceutical industry ranked 58th among the top 100 enterprises in China's pharmaceutical industry. In 2013, the company was awarded the "2012 Top 100 Valuable Listed Companies on China's Main Board" and "Top 100 Golden Bull Listed Companies". In 2014, the company was rated as one of the "Top 10 Pharmaceutical Companies with the Most Investment Value in 2014".
Focusing on the development of the pharmaceutical business, while creating economic benefits for the enterprise, the company has always adhered to the core values of "helping the world, honesty, perseverance and pragmatism", and made due contributions to serving the cause of public health.
